Roivant Sciences Ltd. (ROIV): $10.9
Market Cap: $8.78B
EV: $2.61B
Roivant Sciences (ROIV) stands out in the pharmaceutical industry for two key reasons: its unique business approach and the fascinating background of its founder, Vivek Ramaswamy. Ramaswamy, an American entrepreneur and politician, founded Roivant Sciences in 2014. He gained attention in February 2023 when he announced his candidacy for the Republican Party nomination in the 2024 United States presidential election, though he later suspended his campaign in January 2024 after finishing fourth in Iowa’s caucuses.